Eton Pharmaceuticals, Inc. (ETON)

Eton Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	35.3	32.64	22.89	23.33	0.04	0.96
Revenue Growth (YoY)	35.69%	42.60%	-1.89%	59725.64%	-95.93%	-
Cost of Revenue	11.58	10.58	6.93	2.83	0.44	0.45
Gross Profit	23.72	22.06	15.96	20.51	-0.4	0.51
Selling, General & Admin	18.74	18.93	18.58	14.27	12.61	7.55
Research & Development	3.44	3.32	4	6.24	14.1	11.56
Operating Expenses	22.18	22.25	22.58	20.5	26.71	19.11
Operating Income	1.54	-0.19	-6.62	0.01	-27.11	-18.6
Interest Expense / Income	-0.62	-0.5	0.76	1.01	0.86	-0.28
Other Expense / Income	1	1	1.64	0.95	-	-
Pretax Income	1.16	-0.69	-9.02	-1.96	-27.97	-18.32
Income Tax	0.25	0.25	0	0	0	0
Net Income	0.91	-0.94	-9.02	-1.96	-27.97	-18.32
Shares Outstanding (Basic)	26	26	25	25	21	18
Shares Outstanding (Diluted)	26	26	25	25	21	18
Shares Change	0.93%	1.98%	-0.24%	19.98%	18.29%	176.74%
EPS (Basic)	0.04	-0.04	-0.36	-0.08	-1.33	-1.03
EPS (Diluted)	0.04	-0.04	-0.36	-0.08	-1.33	-1.03
Free Cash Flow	5.88	6.82	4.78	-4.03	-22.4	-19.12
Free Cash Flow Per Share	0.23	0.27	0.19	-0.16	-1.07	-1.08
Gross Margin	67.19%	67.58%	69.71%	87.88%	-1017.95%	52.76%
Operating Margin	4.37%	-0.59%	-28.92%	0.02%	-69515.38%	-1939.62%
Profit Margin	2.59%	-2.87%	-39.41%	-8.38%	-71717.95%	-1910.32%
Free Cash Flow Margin	16.64%	20.88%	20.89%	-17.27%	-57425.64%	-1993.95%
Effective Tax Rate	21.29%	-	-	-	-	-
EBITDA	1.48	-0.29	-6.49	-0.49	-26.46	-18.15
EBITDA Margin	4.20%	-0.89%	-28.33%	-2.09%	-67846.15%	-1893.01%
Depreciation & Amortization	0.94	0.9	1.77	0.46	0.65	0.45
EBIT	0.54	-1.19	-8.26	-0.95	-27.11	-18.6
EBIT Margin	1.54%	-3.65%	-36.08%	-4.07%	-69515.38%	-1939.62%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).